Home › Funds › Soleus Capital Management, L.P. › SUPN
Soleus Capital Management, L.P. position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
Soleus Capital Management, L.P. reported holding 520,000 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$24.2M, representing 0.83% of its reported portfolio and ranking #34 among its reported holdings. Soleus Capital Management, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s SUPN position evolved
Soleus Capital Management, L.P. first disclosed a stake in SUPN in Q2 2026 at 520,000 shares (US$24.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 520.00K | $24.19M | New |
About SUPN and 13F data
SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 34 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SUPN
- MILLENNIUM MANAGEMENT LLC 3.85M sh · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M sh · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M sh · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K sh · $28.55M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K sh · $22.80M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held SUPN?
Soleus Capital Management, L.P. has disclosed SUPN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Soleus Capital Management, L.P.'s current position in SUPN?
As of Q2 2026, Soleus Capital Management, L.P. holds 520.00K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $24.19M, representing 0.83% of its reported portfolio and ranking #34.
Has Soleus Capital Management, L.P. been buying or selling SUPN?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. newly opened its position in SUPN.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.